Silver Coast Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$918K Hold
7,264
0.27% 47
2026
Q1
$1.01M Hold
7,264
0.32% 35
2025
Q4
$892K Sell
7,264
-102
-1% -$12.4K 0.31% 37
2025
Q3
$818K Sell
7,366
-249
-3% -$28.3K 0.28% 38
2025
Q2
$844K Hold
7,615
0.31% 33
2025
Q1
$853K Sell
7,615
-1,019
-12% -$105K 0.32% 30
2024
Q4
$798K Hold
8,634
0.3% 30
2024
Q3
$724K Sell
8,634
-2,023
-19% -$154K 0.27% 30
2024
Q2
$731K Buy
10,657
+1,787
+20% +$119K 0.3% 27
2024
Q1
$650K Buy
8,870
+3,378
+62% +$260K 0.27% 28
2023
Q4
$445K Buy
+5,492
New +$427K 0.2% 33

Other funds holding GILD

Silver Coast Investments's GILD Position: Q2 2026 in Review

Silver Coast Investments held its Gilead Sciences (GILD) position steady in Q2 2026 at 7,264 shares worth $918K. The position accounts for 0.27% of the portfolio, ranked #47.

Silver Coast Investments first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.01M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Silver Coast Investments held 7,264 shares of Gilead Sciences worth $918K as of Q2 2026.
  • Silver Coast Investments left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.27% of Silver Coast Investments's portfolio in Q2 2026, its #47 holding.
  • Silver Coast Investments first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Silver Coast Investments's Gilead Sciences position peaked at $1.01M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Silver Coast Investments's 13F filing for Q2 2026, filed 24 Jul 2026.